comparemela.com

Latest Breaking News On - Masatoshi kudo - Page 1 : comparemela.com

Patients report no quality-of-life issues with adjuvant regimen for high-risk liver cancer

CHICAGO — Individuals with high-risk hepatocellular carcinoma undergoing curative-intent procedures did not experience clinically meaningful deterioration in quality of life or function after adjuvant therapy, phase 3 study results showed.Patient-reported outcomes from the randomized IMbrave050 trial presented at ASCO Annual Meeting suggest that an adjuvant regimen of atezolizumab plus

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.